Human kidney-derived hematopoietic stem cells can support long-term multilineage hematopoiesis.


Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
01 2023
Historique:
received: 28 04 2022
revised: 23 07 2022
accepted: 12 08 2022
pubmed: 16 9 2022
medline: 10 1 2023
entrez: 15 9 2022
Statut: ppublish

Résumé

Long-term multilineage hematopoietic donor chimerism occurs sporadically in patients who receive a transplanted solid organ enriched in lymphoid tissues such as the intestine or liver. There is currently no evidence for the presence of kidney-resident hematopoietic stem cells in any mammal species. Graft-versus-host-reactive donor T cells promote engraftment of graft-derived hematopoietic stem cells by making space in the bone marrow. Here, we report full (over 99%) multilineage, donor-derived hematopoietic chimerism in a pediatric kidney transplant recipient with syndromic combined immune deficiency that leads to transplant tolerance. Interestingly, we found that the human kidney-derived hematopoietic stem cells took up long-term residence in the recipient's bone marrow and gradually replaced their host counterparts, leading to blood type conversion and full donor chimerism of both lymphoid and myeloid lineages. Thus, our findings highlight the existence of human kidney-derived hematopoietic stem cells with a self-renewal ability able to support multilineage hematopoiesis.

Identifiants

pubmed: 36108807
pii: S0085-2538(22)00713-X
doi: 10.1016/j.kint.2022.08.024
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

70-76

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Steicy Sobrino (S)

INSERM UMR_S1163, Institut IMAGINE, Paris, France; Université Paris Cité, Paris, France.

Chrystelle Abdo (C)

Université Paris Cité, Paris, France; Laboratoire d'Onco-Hématologie, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Bénédicte Neven (B)

Université Paris Cité, Paris, France; Service d'Immuno-Hématologie Pédiatrique, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Adeline Denis (A)

INSERM UMR_S1163, Institut IMAGINE, Paris, France.

Nathalie Gouge-Biebuyck (N)

Service de Néphrologie Pédiatrique, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Emmanuel Clave (E)

INSERM UMR_S1160, Institut de Recherche Saint Louis, Paris, France.

Soëli Charbonnier (S)

INSERM UMR_S1163, Institut IMAGINE, Paris, France.

Tifanie Blein (T)

INSERM UMR_S1163, Institut IMAGINE, Paris, France.

Camille Kergaravat (C)

INSERM UMR_S1160, Institut de Recherche Saint Louis, Paris, France.

Marion Alcantara (M)

Université Paris Cité, Paris, France; Laboratoire d'Onco-Hématologie, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Patrick Villarese (P)

Laboratoire d'Onco-Hématologie, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Romain Berthaud (R)

Université Paris Cité, Paris, France; Service de Néphrologie Pédiatrique, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Laurène Dehoux (L)

Service de Néphrologie Pédiatrique, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Souha Albinni (S)

Etablissement Français du Sang Ile-de-France, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Esma Karkeni (E)

Cytometry and Biomarkers UTechS, Center for Translational Science, Institut Pasteur, Paris, France.

Chantal Lagresle-Peyrou (C)

INSERM UMR_S1163, Institut IMAGINE, Paris, France.

Marina Cavazzana (M)

INSERM UMR_S1163, Institut IMAGINE, Paris, France; Université Paris Cité, Paris, France.

Rémi Salomon (R)

Université Paris Cité, Paris, France; Service de Néphrologie Pédiatrique, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Isabelle André (I)

INSERM UMR_S1163, Institut IMAGINE, Paris, France.

Antoine Toubert (A)

Université Paris Cité, Paris, France; INSERM UMR_S1160, Institut de Recherche Saint Louis, Paris, France.

Vahid Asnafi (V)

Université Paris Cité, Paris, France; Laboratoire d'Onco-Hématologie, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Capucine Picard (C)

INSERM UMR_S1163, Institut IMAGINE, Paris, France; Université Paris Cité, Paris, France; CEDI, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Stéphane Blanche (S)

Université Paris Cité, Paris, France; Service d'Immuno-Hématologie Pédiatrique, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Elizabeth Macintyre (E)

Université Paris Cité, Paris, France; Laboratoire d'Onco-Hématologie, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Olivia Boyer (O)

Université Paris Cité, Paris, France; Service de Néphrologie Pédiatrique, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France.

Emmanuelle Six (E)

INSERM UMR_S1163, Institut IMAGINE, Paris, France. Electronic address: emmanuelle.six@inserm.fr.

Julien Zuber (J)

INSERM UMR_S1163, Institut IMAGINE, Paris, France; Université Paris Cité, Paris, France; Service des Maladies du Rein et Métabolisme, Transplantation et Immunologie Clinique, Hôpital Necker, Assistance-Publique Hôpitaux de Paris, Paris, France. Electronic address: julien.zuber@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH